Current evidence for safety and efficacy of anti-programmed cell-death 1 agents in the treatment of cutaneous squamous cell carcinoma: A systematic review. [electronic resource]
- Journal of the American Academy of Dermatology 02 2020
- 522-524 p. digital
Publication Type: Letter; Systematic Review
1097-6787
10.1016/j.jaad.2019.09.044 doi
Adolescent Adult Aged Aged, 80 and over Carcinoma, Squamous Cell--drug therapy Female Humans Male Middle Aged Programmed Cell Death 1 Receptor--antagonists & inhibitors Skin Neoplasms--drug therapy Treatment Outcome Young Adult